Literature DB >> 28699533

Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.

Xiaojing Cong1, Jeremie Topin1, Jerome Golebiowski1.   

Abstract

G protein-coupled receptors (GPCRs), especially the class A, are the most heavily investigated drug targets in the pharmaceutical industry. Tremendous efforts have been made by both industry and academia to understand the molecular structure and function of this large family of transmembrane proteins. Our understanding in GPCR activation has evolved from the classical inactive-active two-state model to a complex view of GPCR conformational ensemble associated with multiple interacting partners such as ligands, allosteric modulators, ions and downstream signaling proteins. New drug targets and ligand design strategies are unveiled. Meanwhile, breakthroughs in X-ray crystallography have resulted in high-resolution structures of over 30 GPCRs, providing structural basis for drug design and functional studies. These enabled wide applications of computational approaches in GPCR research that have led to several groundbreaking studies in the last few years. While a large fraction of human GPCRs has yet to be crystallized, homology modeling plays a pivotal role in the simulation of these GPCRs. Here, we review the recent updates on class A GPCR structure and function, with a focus on the applications and perspectives of molecular modeling in GPCR ligand design. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  GPCR; allosteric modulation; homology modeling; ligand bias; ligand design; molecular dynamics

Mesh:

Substances:

Year:  2017        PMID: 28699533     DOI: 10.2174/1381612823666170710151255

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

2.  Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.

Authors:  Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen
Journal:  J Biomol Struct Dyn       Date:  2019-02-05

3.  Zebrafish olfactory receptors ORAs differentially detect bile acids and bile salts.

Authors:  Xiaojing Cong; Qian Zheng; Wenwen Ren; Jean-Baptiste Chéron; Sébastien Fiorucci; Tieqiao Wen; Chunbo Zhang; Hongmeng Yu; Jérôme Golebiowski; Yiqun Yu
Journal:  J Biol Chem       Date:  2019-03-04       Impact factor: 5.157

Review 4.  Class C GPCRs in the airway.

Authors:  Brijeshkumar S Patel; Jovanka Ravix; Christina Pabelick; Y S Prakash
Journal:  Curr Opin Pharmacol       Date:  2020-05-04       Impact factor: 5.547

5.  Relevance of Hydrogen Bonds for the Histamine H2 Receptor-Ligand Interactions: A Lesson from Deuteration.

Authors:  Mojca Kržan; Jan Keuschler; Janez Mavri; Robert Vianello
Journal:  Biomolecules       Date:  2020-01-29

6.  A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development.

Authors:  Arfaxad Reyes-Alcaraz; Emilio Y Lucero Garcia-Rojas; Elizabeth A Merlinsky; Jae Young Seong; Richard A Bond; Bradley K McConnell
Journal:  Commun Biol       Date:  2022-03-08

7.  Large-Scale G Protein-Coupled Olfactory Receptor-Ligand Pairing.

Authors:  Xiaojing Cong; Wenwen Ren; Jody Pacalon; Rui Xu; Lun Xu; Xuewen Li; Claire A de March; Hiroaki Matsunami; Hongmeng Yu; Yiqun Yu; Jérôme Golebiowski
Journal:  ACS Cent Sci       Date:  2022-02-18       Impact factor: 14.553

8.  Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.

Authors:  Agustín Bruzzese; James A R Dalton; Jesús Giraldo
Journal:  PLoS Comput Biol       Date:  2020-04-16       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.